BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17396143)

  • 1. Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases.
    Cao D; Zhang Q; Wu LS; Salaria SN; Winter JW; Hruban RH; Goggins MS; Abbruzzese JL; Maitra A; Ho L
    Mod Pathol; 2007 May; 20(5):570-8. PubMed ID: 17396143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of maspin in pancreatic ductal adenocarcinoma.
    Lim YJ; Lee JK; Jang WY; Song SY; Lee KT; Paik SW; Rhee JC
    Korean J Intern Med; 2004 Mar; 19(1):15-8. PubMed ID: 15053038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas.
    Ohike N; Maass N; Mundhenke C; Biallek M; Zhang M; Jonat W; Lüttges J; Morohoshi T; Klöppel G; Nagasaki K
    Cancer Lett; 2003 Sep; 199(2):193-200. PubMed ID: 12969792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas.
    Kashima K; Ohike N; Mukai S; Sato M; Takahashi M; Morohoshi T
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):86-90. PubMed ID: 18234645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Foo WC; Rashid A; Wang H; Katz MH; Lee JE; Pisters PW; Wolff RA; Abbruzzese JL; Fleming JB; Wang H
    Hum Pathol; 2013 Jun; 44(6):1024-30. PubMed ID: 23260327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maspin is useful in the distinction of pancreatic adenocarcinoma from chronic pancreatitis: a tissue microarray based study.
    Nash JW; Bhardwaj A; Wen P; Frankel WL
    Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):59-63. PubMed ID: 17536309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas.
    Hong SM; Li A; Olino K; Wolfgang CL; Herman JM; Schulick RD; Iacobuzio-Donahue C; Hruban RH; Goggins M
    Mod Pathol; 2011 Sep; 24(9):1237-47. PubMed ID: 21552209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma.
    Hristov AC; Cope L; Di Cello F; Reyes MD; Singh M; Hillion JA; Belton A; Joseph B; Schuldenfrei A; Iacobuzio-Donahue CA; Maitra A; Resar LM
    Mod Pathol; 2010 Jan; 23(1):98-104. PubMed ID: 19820691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas.
    Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y
    Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of maspin in pancreatic neoplasms: application of maspin immunohistochemistry to the differential diagnosis.
    Oh YL; Song SY; Ahn G
    Appl Immunohistochem Mol Morphol; 2002 Mar; 10(1):62-6. PubMed ID: 11893038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
    Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
    BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic ductal adenocarcinomas with multiple large cystic structures: a clinicopathologic and immunohistochemical study of seven cases.
    Nitta T; Mitsuhashi T; Hatanaka Y; Hirano S; Matsuno Y
    Pancreatology; 2013; 13(4):401-8. PubMed ID: 23890139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.
    Nagao Y; Hisaoka M; Matsuyama A; Kanemitsu S; Hamada T; Fukuyama T; Nakano R; Uchiyama A; Kawamoto M; Yamaguchi K; Hashimoto H
    Mod Pathol; 2012 Jan; 25(1):112-21. PubMed ID: 21983937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis.
    Boltze C
    Pathol Res Pract; 2005; 200(11-12):783-90. PubMed ID: 15792121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas.
    Liu H; Shi J; Anandan V; Wang HL; Diehl D; Blansfield J; Gerhard G; Lin F
    Arch Pathol Lab Med; 2012 Jun; 136(6):601-9. PubMed ID: 22646265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR expression in pancreatic intraepithelial neoplasia and ductal adenocarcinoma.
    Park SJ; Gu MJ; Lee DS; Yun SS; Kim HJ; Choi JH
    Int J Clin Exp Pathol; 2015; 8(7):8298-304. PubMed ID: 26339400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High nuclear Survivin expression as a poor prognostic marker in pancreatic ductal adenocarcinoma.
    Zhou L; Lu J; Liang ZY; Zhou WX; Yuan D; Li BQ; You L; Guo JC; Zhao YP
    J Surg Oncol; 2018 Dec; 118(7):1115-1121. PubMed ID: 30261114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of immunohistochemical RhoA expression on survival in pancreatic ductal adenocarcinoma: a high-throughput analysis.
    Dittert DD; Kielisch C; Alldinger I; Zietz C; Meyer W; Dobrowolski F; Saeger HD; Baretton GB
    Hum Pathol; 2008 Jul; 39(7):1002-10. PubMed ID: 18495213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
    Zhao L; Cui Q; Lu Z; Chen J
    Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.